Equidacent - patient leaflet, side effects, dosage
Sources: Original PDF (ema.europa.eu)
The drug is classified in the ATC tree:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS in ATC
L01XC Monoclonal antibodies, antineoplastic
L01XC07 bevacizumab